These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 8054907)
1. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Slavin MA; Meyers JD; Remington JS; Hackman RC Bone Marrow Transplant; 1994 May; 13(5):549-57. PubMed ID: 8054907 [TBL] [Abstract][Full Text] [Related]
2. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424 [TBL] [Abstract][Full Text] [Related]
4. Toxoplasma infection after human allogeneic bone marrow transplantation: clinical and serological study of 80 patients. Derouin F; Gluckman E; Beauvais B; Devergie A; Melo R; Monny M; Lariviere M Bone Marrow Transplant; 1986 May; 1(1):67-73. PubMed ID: 3332121 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasmosis after hematopoietic stem cell transplantation. Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751 [TBL] [Abstract][Full Text] [Related]
6. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Peacock JE; Greven CM; Cruz JM; Hurd DD Bone Marrow Transplant; 1995 Jun; 15(6):983-7. PubMed ID: 7581102 [TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review. Martina MN; Cervera C; Esforzado N; Linares L; Torregrosa V; Sanclemente G; Hoyo I; Cofan F; Oppenheimer F; Miro JM; Campistol JM; Moreno A Transpl Int; 2011 Jan; 24(1):e6-12. PubMed ID: 20955469 [TBL] [Abstract][Full Text] [Related]
8. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578 [TBL] [Abstract][Full Text] [Related]
9. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals]. Piergili Fioretti D Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712 [TBL] [Abstract][Full Text] [Related]
10. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Chandrasekar PH; Momin F Bone Marrow Transplant; 1997 Apr; 19(7):685-9. PubMed ID: 9156245 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Janitschke K; Held T; Krüiger D; Schwerdtfeger R; Schlier G; Liesenfeld O Clin Lab; 2003; 49(5-6):239-42. PubMed ID: 15285180 [TBL] [Abstract][Full Text] [Related]
12. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Rogers NM; Peh CA; Faull R; Pannell M; Cooper J; Russ GR Transpl Infect Dis; 2008 Feb; 10(1):71-4. PubMed ID: 17605745 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Sing A; Leitritz L; Roggenkamp A; Kolb HJ; Szabados A; Fingerle V; Autenrieth IB; Heesemann J Clin Infect Dis; 1999 Aug; 29(2):429-33. PubMed ID: 10476754 [TBL] [Abstract][Full Text] [Related]
14. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy. Duband S; Cornillon J; Tavernier E; Dumollard JM; Guyotat D; Péoc'h M Transpl Infect Dis; 2008 Oct; 10(5):372-4. PubMed ID: 18384483 [TBL] [Abstract][Full Text] [Related]
15. [Development of a real-time PCR assay for quantitative diagnosis of Toxoplasma gondii after allogeneic bone marrow transplantation]. Daval S; Poirier P; Armenaud J; Cambon M; Livrelli V Pathol Biol (Paris); 2010 Feb; 58(1):104-9. PubMed ID: 19892493 [TBL] [Abstract][Full Text] [Related]
16. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [TBL] [Abstract][Full Text] [Related]
17. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Foot AB; Garin YJ; Ribaud P; Devergie A; Derouin F; Gluckman E Bone Marrow Transplant; 1994 Aug; 14(2):241-5. PubMed ID: 7994239 [TBL] [Abstract][Full Text] [Related]
19. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. de Medeiros BC; de Medeiros CR; Werner B; Loddo G; Pasquini R; Bleggi-Torres LF Transpl Infect Dis; 2001 Mar; 3(1):24-8. PubMed ID: 11429036 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry. Held TK; Krüger D; Switala AR; Beyer J; Kingreen D; Busemann C; Janitschke K; Siegert W Bone Marrow Transplant; 2000 Jun; 25(12):1257-62. PubMed ID: 10871730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]